|
|
|
Insider
Information: |
Kaye Edward M. Md |
Relationship: |
Director |
City: |
Bothell |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
123,146 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$9,667,795 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
123,146 |
|
|
Total
Value |
$9,667,795 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2017-08-03 |
71,229 |
2015-02-27 |
0 |
Premium* |
|
Stoke Therapeutics, Inc. |
STOK |
|
2024-05-20 |
27,000 |
2019-12-16 |
0 |
Premium* |
|
Cytokinetics Inc |
CYTK |
Director |
2024-05-15 |
24,917 |
2020-10-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SRPT |
Sarepta Therapeutics Inc |
SVP & Chief Medical Officer |
|
2015-02-27 |
4 |
B |
$11.82 |
$9,452 |
D/D |
800 |
1,311 |
2.74 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
SVP Interim CEO & CMO |
|
2015-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
110,783 |
112,094 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
SVP Interim CEO & CMO |
|
2015-07-20 |
4 |
D |
$33.48 |
$100,440 |
D/D |
(3,000) |
109,094 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
SVP Interim CEO & CMO |
|
2015-10-20 |
4 |
D |
$26.74 |
$80,247 |
D/D |
(3,001) |
106,893 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
SVP Interim CEO & CMO |
|
2016-01-20 |
4 |
D |
$13.26 |
$44,660 |
D/D |
(3,368) |
103,525 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
SVP Interim CEO & CMO |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,704 |
109,029 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
SVP Interim CEO & CMO |
|
2016-04-20 |
4 |
D |
$19.71 |
$59,150 |
D/D |
(3,001) |
106,028 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
SVP Interim CEO & CMO |
|
2016-07-20 |
4 |
D |
$22.46 |
$67,402 |
D/D |
(3,001) |
103,027 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
SVP Interim CEO & CMO |
|
2016-08-31 |
4 |
D |
$26.07 |
$38,766 |
D/D |
(1,487) |
101,540 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
President, CEO & CMO |
|
2016-09-19 |
4 |
OE |
$5.40 |
$168,941 |
D/D |
24,352 |
87,388 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
President, CEO & CMO |
|
2016-09-19 |
4 |
AS |
$50.00 |
$1,217,600 |
D/D |
(24,352) |
76,983 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
President, CEO & CMO |
|
2016-09-22 |
4 |
OE |
$8.28 |
$332,682 |
D/D |
40,179 |
117,162 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
President, CEO & CMO |
|
2016-09-22 |
4 |
AS |
$60.00 |
$2,410,740 |
D/D |
(40,179) |
76,983 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
President, CEO & CMO |
|
2016-10-20 |
4 |
D |
$49.05 |
$213,269 |
D/D |
(4,348) |
72,635 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
President, CEO & CMO |
|
2016-11-09 |
4 |
OE |
$8.28 |
$24,840 |
D/D |
3,000 |
75,635 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
President, CEO & CMO |
|
2017-01-20 |
4 |
D |
$32.66 |
$145,860 |
D/D |
(4,466) |
71,169 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
President & CEO |
|
2017-04-20 |
4 |
D |
$32.54 |
$141,516 |
D/D |
(4,349) |
66,820 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2017-07-20 |
4 |
D |
$40.93 |
$178,005 |
D/D |
(4,349) |
62,471 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2017-07-20 |
4 |
AS |
$41.00 |
$410,000 |
D/D |
(10,000) |
52,471 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2017-08-03 |
4 |
D |
$37.88 |
$632,710 |
D/D |
(16,703) |
71,229 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2017-08-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,461 |
87,932 |
0 |
- |
|
STOK |
Stoke Therapeutics, Inc. |
CEO |
|
2019-12-16 |
4 |
OE |
$0.60 |
$30,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-10-05 |
4 |
OE |
$7.61 |
$152,200 |
D/D |
20,000 |
20,000 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2020-10-05 |
4 |
AS |
$30.00 |
$600,000 |
D/D |
(20,000) |
0 |
0 |
% |
|
STOK |
Stoke Therapeutics, Inc. |
CEO |
|
2020-11-25 |
4 |
AS |
$50.00 |
$642,400 |
D/D |
(12,848) |
37,152 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|